Actively Recruiting
Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer
Led by Peking University Cancer Hospital & Institute · Updated on 2025-04-16
500
Participants Needed
4
Research Sites
173 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This multicenter retrospective real-world study aims to evaluate the safety, efficacy and survival outcomes of neoadjuvant/induction immunotherapy in patients with non-small cell lung cancer (NSCLC). The study covers diverse treatment pathways, including surgery, definitive radiotherapy, and non-surgical strategies. It addresses gaps in existing trials by establishing a comprehensive cohort spanning neoadjuvant/induction therapy, perioperative management, and follow-up, providing real-world evidence to support treatment decisions in both operable and inoperable cases.
CONDITIONS
Official Title
Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed non-small cell lung cancer (NSCLC), regardless of EGFR or ALK mutations
- Clinical stage IA to IIIC according to AJCC 8th Edition before neoadjuvant treatment
- Received at least one cycle of neoadjuvant immunotherapy with or without chemotherapy
- Assessed as resectable or potentially resectable by surgical experts before treatment
You will not qualify if you...
- Confirmed M1 disease (distant metastasis)
- History of previous lung malignancy or other metastatic malignant tumors
- Participation in other randomized controlled trials involving neoadjuvant treatment
- Significant missing clinical data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Peking University Cancer Hospital & Institute
Beijing, Beijing Municipality, China, 100142
Actively Recruiting
2
Peking University Third Hospital
Beijing, Beijing Municipality, China
Actively Recruiting
3
Inner Mongolia Hospital of Peking University Cancer Hospital
Hohhot, Inner Mongolia, China
Actively Recruiting
4
The Third Affliated Hospital of Kunming Medical University
Kunming, Yunnan, China
Actively Recruiting
Research Team
N
Nan Wu, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here